Medicare Enrolled

Dr. Faustino Macuha, MD

Endocrinology · The Villages, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2955 BROWNWOOD BLVD, The Villages, FL 32163
3526748700
In practice since 2009 (17 years)
NPI: 1548402423 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Macuha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macuha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Macuha

Dr. Faustino Macuha is an endocrinology in The Villages, FL, with 17 years in practice. Based on federal Medicare data, Dr. Macuha performed 2,267 Medicare services across 939 unique beneficiaries.

Between the years covered by Open Payments, Dr. Macuha received a total of $20,903 from 50 pharmaceutical and/or device companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Macuha is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 25% volume in FL$ $20,903 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,267
Medicare services
Top 25% in FL for endocrinology
939
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~133 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)840$18$30
Office visit, established patient (30-39 min)672$93$192
Blood draw (venipuncture)201$6$6
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report159$26$56
New patient office visit (45-59 min)123$117$255
Bone density scan (DEXA)68$36$76
Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment49$49$85
Hemoglobin A1c test (diabetes monitoring)49$10$13
Office visit, established patient, complex (40-54 min)36$140$275
Drug injection, under skin or into muscle33$9$31
Fine needle aspiration biopsy using ultrasound guidance, first growth21$106$192
Office visit, established patient (20-29 min)16$65$140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,903
Total received (2018-2024)
Avg $2,986/year across 7 years
Top 18% in FL for endocrinology
50
Companies
491
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,693 (60.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,211 (39.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,964
2023
$1,948
2022
$3,041
2021
$1,444
2020
$650
2019
$2,376
2018
$2,479

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$8,469
Novo Nordisk Inc
$2,524
Amgen Inc.
$1,377
Lilly USA, LLC
$1,189
AstraZeneca Pharmaceuticals LP
$1,133
Medtronic, Inc.
$841
Corcept Therapeutics
$430
Boehringer Ingelheim Pharmaceuticals, Inc.
$356
SANOFI-AVENTIS U.S. LLC
$344
Janssen Pharmaceuticals, Inc
$296
Tandem Diabetes Care, Inc.
$285
Esperion Therapeutics, Inc.
$258
GENZYME CORPORATION
$245
Xeris Pharmaceuticals, Inc.
$213
MannKind Corporation
$199
PFIZER INC.
$190
Averitas Pharma Inc.
$189
Dexcom, Inc.
$172
Boston Scientific Corporation
$168
Edwards Lifesciences Corporation
$154
Merck Sharp & Dohme Corporation
$152
Horizon Therapeutics plc
$145
Insulet Corporation
$132
GRT US Holding, Inc.
$125
Ascendis Pharma Inc
$123
Bayer Healthcare Pharmaceuticals Inc.
$114
Bayer HealthCare Pharmaceuticals Inc.
$109
Kyowa Kirin, Inc.
$101
AIMMUNE THERAPEUTICS, INC.
$100
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$95
Merck Sharp & Dohme LLC
$87
Radius Health, Inc.
$85
ABBVIE INC.
$84
Medtronic MiniMed, Inc.
$53
IBSA Pharma Inc.
$51
Eisai Inc.
$45
Ipsen Biopharmaceuticals, Inc
$33
Companion Medical, Inc.
$25
Astellas Pharma US Inc
$24
RECORDATI_RARE_DISEASES_INC.
$23
BETA BIONICS, INC.
$22
AbbVie Inc.
$20
Amarin Pharma Inc.
$18
Sunovion Pharmaceuticals Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
AbbVie, Inc.
$16
Strongbridge US INC.
$16
VIVUS LLC
$15
Shire North American Group Inc
$14
Smith & Nephew, Inc.
$11
Top 3 companies account for 59.2% of total payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BASAGLAR · BELSOMRA · BRILINTA · BYDUREON · Crysvita · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LONHALA MAGNAIR · LYUMJEV · Lenvima · LifeVest · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Omnipod · Ozempic · PREVNAR - 13 · Prolia · QSYMIA · QUTENZA · Qutenza · RECORLEV · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Santyl · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · V-GO · VERQUVO · Vascepa · Victoza · WATCHMAN FLX · Wegovy · XARELTO · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $922 per 100 Medicare services performed
Looking for a endocrinology in The Villages?
Compare endocrinologys in the The Villages area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
13
Per 100K population
9.5
County median income
$73,297
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Macuha is a clinical cardiology specialist, with above-average Medicare volume (top 25% in FL), and high industry engagement (low-engagement, top 18%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Macuha experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Macuha performed 840 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macuha receive payments from pharmaceutical companies?
Yes. Dr. Macuha received a total of $20,903 from 50 companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macuha's costs compare to other endocrinologys in The Villages?
Dr. Macuha's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macuha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →